Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Oryctolagus cuniculus | Acyl-CoA:cholesterol acyltransferase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus granulosus | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma mansoni | sterol O-acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Echinococcus multilocularis | sterol O acyltransferase 1 | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Schistosoma japonicum | ko:K00637 sterol O-acyltransferase [EC2.3.1.26], putative | Get druggable targets OG5_133487 | All targets in OG5_133487 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Dictyostelium discoideum | diacylglycerol O-acyltransferase 1 | Acyl-CoA:cholesterol acyltransferase | 305 aa | 278 aa | 21.9 % |
Neospora caninum | sterol O-acyltransferase, putative | Acyl-CoA:cholesterol acyltransferase | 305 aa | 258 aa | 20.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0065 | 0.0379 | 1 |
Toxoplasma gondii | 1,3-beta-glucan synthase component protein | 0.0219 | 0.4219 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0452 | 1 | 1 |
Schistosoma mansoni | sterol O-acyltransferase 1 | 0.0264 | 0.533 | 0.9001 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.295 | 0.4974 |
Echinococcus granulosus | geminin | 0.0168 | 0.295 | 0.2943 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0452 | 1 | 1 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.0192 | 0.3549 | 0.3543 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0065 | 0.0379 | 0.0876 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.001 | 0.5 |
Echinococcus multilocularis | geminin | 0.0168 | 0.295 | 0.2943 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0065 | 0.0379 | 1 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0065 | 0.0379 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.005 | 0.001 | 0.0015 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0065 | 0.0379 | 0.0369 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0054 | 0.0111 | 0.0102 |
Loa Loa (eye worm) | MBCTL1 | 0.0054 | 0.0111 | 0.0168 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0111 | 0.0168 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.0192 | 0.3549 | 0.5345 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0186 | 0.3407 | 0.34 |
Echinococcus multilocularis | sterol O acyltransferase 1 | 0.0264 | 0.533 | 0.5326 |
Loa Loa (eye worm) | STAT protein | 0.0317 | 0.664 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0452 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 0.533 | 0.8028 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.001 | 0.5 |
Brugia malayi | STAT protein, DNA binding domain containing protein | 0.0317 | 0.664 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0168 | 0.295 | 0.4974 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0192 | 0.3549 | 0.5345 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.001 | 0.5 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0186 | 0.3407 | 0.34 |
Loa Loa (eye worm) | hypothetical protein | 0.0238 | 0.469 | 0.7063 |
Trichomonas vaginalis | CMGC family protein kinase | 0.005 | 0.001 | 0.5 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0065 | 0.0379 | 0.0624 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.0192 | 0.3549 | 0.5 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0054 | 0.0111 | 0.0168 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.005 | 0.001 | 0.0015 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.0192 | 0.3549 | 0.3543 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0065 | 0.0379 | 0.0369 |
Giardia lamblia | Kinase, CMGC MAPK | 0.005 | 0.001 | 0.5 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0054 | 0.0111 | 0.0102 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0054 | 0.0111 | 0.0102 |
Schistosoma mansoni | hypothetical protein | 0.0288 | 0.5921 | 1 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0065 | 0.0379 | 1 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0054 | 0.0111 | 0.0102 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0065 | 0.0379 | 1 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0054 | 0.0111 | 0.0172 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.0192 | 0.3549 | 0.5988 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0065 | 0.0379 | 0.057 |
Echinococcus granulosus | sterol O acyltransferase 1 | 0.0264 | 0.533 | 0.5326 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Delta TC (functional) | = -75 % | Percent change in total cholesterol in peanut oil (5.5%)-, cholic acid (0.3%)-, Cholesterol (1.5%)-fed rats after a single dose. | ChEMBL. | 8201599 |
IC50 (binding) | = 0.021 uM | Tested for in vitro inhibition against Acyl coenzyme A:cholesterol acyltransferase of intestinal microsomes in cholesterol-fed rabbits | ChEMBL. | 8201599 |
IC50 (binding) | = 0.021 uM | Tested for in vitro inhibition against Acyl coenzyme A:cholesterol acyltransferase of intestinal microsomes in cholesterol-fed rabbits | ChEMBL. | 8201599 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.